Carolina Alarcón-Payer

866 total citations
40 papers, 362 citations indexed

About

Carolina Alarcón-Payer is a scholar working on Physical and Theoretical Chemistry, Materials Chemistry and Genetics. According to data from OpenAlex, Carolina Alarcón-Payer has authored 40 papers receiving a total of 362 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Physical and Theoretical Chemistry, 10 papers in Materials Chemistry and 8 papers in Genetics. Recurrent topics in Carolina Alarcón-Payer's work include Crystallography and molecular interactions (13 papers), Crystallization and Solubility Studies (10 papers) and Chronic Lymphocytic Leukemia Research (8 papers). Carolina Alarcón-Payer is often cited by papers focused on Crystallography and molecular interactions (13 papers), Crystallization and Solubility Studies (10 papers) and Chronic Lymphocytic Leukemia Research (8 papers). Carolina Alarcón-Payer collaborates with scholars based in Spain, Italy and Slovakia. Carolina Alarcón-Payer's co-authors include Duane Choquesillo‐Lazarte, J. Niclós‐Gutiérrez, A. Castiñeiras, J.M. González-Pérez, Tiziana Pivetta, Guido Crisponi, Alicia Domínguez‐Martín, M. León‐Sanz, Rafael Ríos and Luís Lezama and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and Inorganic Chemistry.

In The Last Decade

Carolina Alarcón-Payer

32 papers receiving 357 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carolina Alarcón-Payer Spain 11 119 117 83 72 62 40 362
Xing-Fu Li China 15 255 2.1× 56 0.5× 186 2.2× 59 0.8× 32 0.5× 49 659
Sean X. Gu United States 11 43 0.4× 61 0.5× 84 1.0× 152 2.1× 82 1.3× 27 658
Angeliki Galani Greece 9 117 1.0× 121 1.0× 23 0.3× 129 1.8× 14 0.2× 14 444
B.S. Potter United Kingdom 14 69 0.6× 78 0.7× 69 0.8× 121 1.7× 54 0.9× 60 688
Hideaki Kanno Japan 12 186 1.6× 123 1.1× 238 2.9× 39 0.5× 63 1.0× 36 718
Yuhua Mei China 14 87 0.7× 138 1.2× 115 1.4× 108 1.5× 10 0.2× 32 482
Hamsell M. Alvarez United States 8 107 0.9× 165 1.4× 52 0.6× 50 0.7× 6 0.1× 11 421
C. Balagopalakrishna United States 11 93 0.8× 81 0.7× 66 0.8× 108 1.5× 9 0.1× 14 398
M. Damodara Poojary India 10 190 1.6× 62 0.5× 137 1.7× 122 1.7× 7 0.1× 21 435
Hidetoshi Inoue Japan 16 64 0.5× 103 0.9× 131 1.6× 93 1.3× 13 0.2× 80 597

Countries citing papers authored by Carolina Alarcón-Payer

Since Specialization
Citations

This map shows the geographic impact of Carolina Alarcón-Payer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carolina Alarcón-Payer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carolina Alarcón-Payer more than expected).

Fields of papers citing papers by Carolina Alarcón-Payer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carolina Alarcón-Payer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carolina Alarcón-Payer. The network helps show where Carolina Alarcón-Payer may publish in the future.

Co-authorship network of co-authors of Carolina Alarcón-Payer

This figure shows the co-authorship network connecting the top 25 collaborators of Carolina Alarcón-Payer. A scholar is included among the top collaborators of Carolina Alarcón-Payer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carolina Alarcón-Payer. Carolina Alarcón-Payer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Alarcón-Payer, Carolina, Antonio Frontera, Rafel Prohens, et al.. (2025). Seeking new polymorphs in pharmaceutical cocrystals: focus on furosemide–ethenzamide. CrystEngComm. 28(1). 88–100.
2.
3.
Alarcón-Payer, Carolina, Alicia Domínguez‐Martín, Antonio Frontera, et al.. (2025). Exploring Sublimation as a Tool for Polymorphic Screening in Niflumic Acid–Caffeine Pharmaceutical Cocrystals. Crystal Growth & Design. 25(21). 9137–9149.
4.
Alarcón-Payer, Carolina, et al.. (2024). 4CPS-028 Analysis of interactions detected in the concomitant use of antineoplastic agents and phytotherapy in onco-haematology practice and interventions carried out. Section 4: Clinical pharmacy services. A64.2–A64. 1 indexed citations
5.
Alarcón-Payer, Carolina, et al.. (2024). 4CPS-027 Analysis of cardiovascular risk associated with irreversible inhibitor of Bruton’s tyrosine kinase treatment in patients with chronic lymphoid leukaemia. Section 4: Clinical pharmacy services. A64.1–A64. 1 indexed citations
6.
Alarcón-Payer, Carolina, et al.. (2024). Characteristics of Chronic Kidney Disease Patients Undergoing Hemodialysis at RSPAL Dr. Ramelan Surabaya from January to June 2022. SHILAP Revista de lepidopterología. 17(3). 225–237. 1 indexed citations
7.
Alarcón-Payer, Carolina, et al.. (2023). Treatment of Chronic Lymphocytic Leukemia in the Personalized Medicine Era. Pharmaceutics. 16(1). 55–55. 2 indexed citations
8.
Alarcón-Payer, Carolina, et al.. (2023). Risk factors determining adherence to tyrosine kinase inhibitors in chronic myeloid leukaemia. Journal of Oncology Pharmacy Practice. 30(5). 902–906. 3 indexed citations
9.
10.
Domínguez‐Martín, Alicia, et al.. (2023). Evaluation of synthon influence on ethenzamide–polyphenol pharmaceutical cocrystals. CrystEngComm. 25(21). 3150–3163. 3 indexed citations
11.
Alarcón-Payer, Carolina, et al.. (2022). Towards the Development of Novel Diclofenac Multicomponent Pharmaceutical Solids. Crystals. 12(8). 1038–1038. 8 indexed citations
12.
Alarcón-Payer, Carolina, et al.. (2022). Impact of Genetic Polymorphisms and Biomarkers on the Effectiveness and Toxicity of Treatment of Chronic Myeloid Leukemia and Acute Myeloid Leukemia. Journal of Personalized Medicine. 12(10). 1607–1607. 3 indexed citations
13.
Verdugo‐Escamilla, Cristóbal, et al.. (2022). Lidocaine Pharmaceutical Multicomponent Forms: A Story about the Role of Chloride Ions on Their Stability. Crystals. 12(6). 798–798. 5 indexed citations
14.
Verdugo‐Escamilla, Cristóbal, Carolina Alarcón-Payer, Antonio Frontera, et al.. (2020). Interconvertible Hydrochlorothiazide–Caffeine Multicomponent Pharmaceutical Materials: A Solvent Issue. Crystals. 10(12). 1088–1088. 12 indexed citations
15.
Pérez-Ramírez, Cristina, et al.. (2018). FCGR2A/FCGR3A Gene Polymorphisms and Clinical Variables as Predictors of Response to Tocilizumab and Rituximab in Patients With Rheumatoid Arthritis. The Journal of Clinical Pharmacology. 59(4). 517–531. 36 indexed citations
16.
Ríos, Rafael, et al.. (2017). Pomalidomide in the treatment of multiple myeloma: design, development and place in therapy. Drug Design Development and Therapy. Volume 11. 2399–2408. 32 indexed citations
17.
Alarcón-Payer, Carolina, et al.. (2014). Individualized measurement of disease-related malnutrition's costs. Clinical Nutrition. 34(5). 951–955. 22 indexed citations
18.
González-Pérez, J.M., Carolina Alarcón-Payer, A. Castiñeiras, et al.. (2005). A Windmill-Shaped Hexacopper(II) Molecule Built Up by Template Core-Controlled Expansion of Diaquatetrakis(μ2-adeninato-N3,N9)dicopper(II) with Aqua(oxydiacetato)copper(II). Inorganic Chemistry. 45(2). 877–882. 50 indexed citations
19.
Choquesillo‐Lazarte, Duane, et al.. (2003). An aqua-adenine H-bonding interaction controlling the formation of the rare Zn(II)–N9(adenine) bond in crystal structure of diaqua(adenine)(iminodiacetato)zinc(II). Inorganic Chemistry Communications. 6(11). 1354–1357. 31 indexed citations
20.
Leo, Paul & Carolina Alarcón-Payer. (1989). [Fowler-Stephens orchidopexy].. PubMed. 10(9). 489–90. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xing-Fu Li Breakdown of academic impact, for papers by Sean X. Gu Breakdown of academic impact, for papers by Angeliki Galani Breakdown of academic impact, for papers by B.S. Potter Breakdown of academic impact, for papers by Hideaki Kanno Breakdown of academic impact, for papers by Yuhua Mei Breakdown of academic impact, for papers by Hamsell M. Alvarez Breakdown of academic impact, for papers by C. Balagopalakrishna Breakdown of academic impact, for papers by M. Damodara Poojary Breakdown of academic impact, for papers by Hidetoshi Inoue
Rankless by CCL
2026